The TITRATION trial assessed tolerability of initiating/uptitrating sacubitril/valsartan using a conservative or condensed regimen in HFrEF patients...
As per this study, selectively created non-randomized real-world data might be valuable in establishing supplemental drug indications of medication...
Prasugrel is Superior or Equivalent to Ticagrelor in ACS Patients undergoing PCI: A Systematic Review and Meta-Analysis
Meta-analysis of 9 trials indicates that prasugrel is equivalent or superior to ticagrelor in ACS patients undergoing PCI.
Efficacy and Safety of Sacubitril/Valsartan in HFrEF Patients with Low SBP: Insights from PARADIGM-HF
The present analysis evaluated the efficacy and safety of sacubitril/over enalapril in HF patients across different levels of SBP.
Macitentan is an orally active, potent, tissue targeting ERA that is indicated for the treatment of pulmonary arterial hypertension (PAH). It is the...